33
Views
12
CrossRef citations to date
0
Altmetric
Review

Varicella zoster virus: vaccination and implications in children with renal failure

&
Pages 291-298 | Published online: 09 Jan 2014

References

  • Holt LE. The diseases of infancy and childhood. In: !!!!!!The Classics of Pediatrics Library DeAngelis C (Ed.), Gryphon Editions, NY, USA, 929–936 (1994).
  • Wharton M. The epidemiology of varicella zoster infections. Infect. Dis. Clin. North Am. 10(3), 571–581 (1996).
  • Centers for Disease Control and Prevention. Varicella. In: The Pink Book: Epidemiology & Prevention of Vaccine Preventable Diseases, gh Edition. Public Health Foundation, 159–175 (2004).
  • ••Review of varicella-related disease,epidemiology and prevention.
  • American Academy of Pediatrics. Varicella zoster infections. In: Red book: 2003 Report of the Committee on Infectious Diseases. Pickering LK (Ed.), American Academy of Pediatrics, IL, USA, 672–686 (2003).
  • ••Comprehensive guidelines on vaccinationand treatment of varicella-related disease in immunocompetent and immunocompromised children.
  • Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J. Infect. Dis. 172(3), 706–712 (1995).
  • Feldhoff CM, Balfour HH, Simmons RL, Najarian JS, Mauer SM. Varicella in children with renal transplants. J Pediatr. 98(1), 25–31 (1981).
  • Lynfield R, Herrin JT, Rubin RH. Varicella in pediatric renal transplant recipients. Pediatrics 90(2), 216–220 (1992).
  • Kashtan CE, Cook M, Chavers BM, Mauer SM, Nevins TE. Outcome of chickenpox in 66 pediatric renal transplant recipients. J Pediatr. 131(6), 874–877 (1997).
  • Furth SL, Sullivan EK, Neu AM, Tejani A, Fivush BA. Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Co-operative Study (NAPRTCS). Pediatr. Transplant 1(1) 37–42 (1997).
  • Fehr T, Bossart W, Wahl C, Binswanger U. Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature. Transplantation 73(4), 608–611 (2002).
  • McGregor RS, Zitelli BJ, Urbach Aft Malatack JJ, Gartner JC. Varicella in pediatric orthotopic liver transplant recipients. Pediatrics 83 (2), 256–261 (1989).
  • Centers for Disease Control and Prevention. Decline in annual incidence of varicella-selected states, 1990–2001. Morb. Mortal. Wkly Rep. 52(37), 884–885 (2003).
  • Gershon AA, Steinberg SP, Gelb L et al Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA 252(3), 355–362 (1984).
  • Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 78 (4), 757–762 (1986).
  • Levin MJ, Gershon AA, Weinberg A et al. and the AIDS Clinical Trials Group 265 Team. Immunization of HIV-infected children with varicella vaccine. J Pediatr. 139(2), 305–310 (2001).
  • Wise RP, Salive ME, Braun MM et al Post licensure safety surveillance for varicella vaccine. JAMA 284(10), 1271–1279 (2000).
  • National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am. J Kidney Dis. 39\(Suppl. 1), S1—S266 (2002).
  • US Renal Data System. Atlas of end-stage renal disease in the USA. USRDS 2002 Annual Data Report (2002).
  • Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 51(6), 1908–1919 (1997).
  • Wright JT, Bakris G, Greene T et al. African—American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288(19), 2421–2431 (2002).
  • Coresh J, Wei GL, McQuillan G et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988–1994). Arch. Intern. Med. 161(9), 1207–1216 (2001).
  • Esbjorner E, Berg U, Hansson S. Epidemiology of chronic renal failure in children: a report from Sweden 1986–1994. Swedish Pediatric Nephrology Association. Pediatr. Nephrol. 11(4), 438–442 (1997).
  • Abdurrahman MB, Elidrissy AT. Childhood renal disorders in Saudi Arabia. Pediatr. Nephrol. 2(3), 368–372 (1988).
  • Lagomarsimo E, Valenzuela A, Cavagnaro F, Solar E. Chronic renal failure in pediatrics 1996. Chilean survey. Pediatr. Nephrol. 13(4), 288–291 (1999).
  • Wyatt RJ, Kagy L, Kritchevsky SB. Epidemiology of pediatric kidney diseases. Pediatr. Ann. 25(5), 288–296 (1996).
  • Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A. Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. Pediatr. Nephrol. 18(8), 796–804 (2003).
  • Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect. Dis. Clin. North Am. 15(3), 813–832 (2001).
  • Bereed K, Wright M, Eadington D, Farr M, Sellars L. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgrad. Med. J. 78(923), 538–540 (2002).
  • Peces R, Laures AS. Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine: role of a booster dose on antibody response. Nephron 89(2), 172–176 (2001).
  • Marangi AL, Giordano R, Montanaro A et al. Hepatitis B virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination. Am. J Kidney Dis. 23(4), 537–542 (1994).
  • Sezer S, Ozdemir FN, Guz G et al Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc. 32(3), 607–608 (2000).
  • Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ. Response to measles—mumps—rubella vaccine in children on dialysis. Pediatr. Nephrol. 6(2), 187–189 (1992).
  • Caydar C, Sayan M, Sifil A et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand. UroL Nephrol. 37(1), 71–76 (2003).
  • Suga T, Niki H, Niikura M et al Influenza antibody titers after vaccination of chronic renal failure patients; before and during hemodialysis, or on continuous ambulatory peritoneal dialysis. Tokai J. Exp. Clin. Med. 15(2–3), 245–251 (1990).
  • Fuchshuber A, Kuhnemund 0, Keuth B etal. Penumococcal vaccine in children and young adults with chronic renal disease. NephroL Dial. Tmnplant.11 (3), 468–473 (1996).
  • Kruger S, Muller-Steinhardt M, Kirchner H, Kreft B. A 5-year follow-up of antibody response after diphtheria and tetanus vaccination in hemodialysis patients. Am. J. Kidney Dis. 38(6), 1264–1270 (2001).
  • Kruger S, Seyfarth M, Sack K, Kreft B. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination. Vaccine 17(9-10), 1145–1150 (1999).
  • Brayer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C. Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 99(1), 35–39 (1997).
  • Webb NJ, Fitzpatrick MM, Hughes DA et al Immunization against varicella in end stage and pre-end stage renal failure. Trans-Pennine Paediatric Nephrology Study Group. Arch. Dis. Child. 82(2), 141–143 (2000).
  • Furth SL, Hogg RI Tarver J et al. Varicella vaccination in children with chronic renal failure. A report of the Southwest Pediatric Nephrology Study Group. Pediatr. NephroL 18(1), 33–38 (2003).
  • White CJ, Kuter BJ, Ngai A et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr. Infect. Dis. 11(1), 19–23 (1992).
  • Vessey SJ, Chan CY, Kuter BJ et al. Childhood vaccination against varicella: persistence of antibody, duration of protection and vaccine efficacy. J. Pediatr. 139(2), 297–304 (2001).
  • Olson AD, Shope TC, Flynn JT. Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation. Pediatr. Transplant. 5(1), 44–50 (2001).
  • Crespo JF, Gorriz JL, Avila A et al. Prevalence of past varicella zoster virus infection in candidates for kidney transplantation: vaccination in seronegatiye patients. Transplant. Proc. 34(1), 77 (2002).
  • Gershon AA. Varicella vaccine: rare serious problems — but the benefits still outweigh the risks. J. Infect. Dis. 188(7), 945–947 (2003).
  • Sharrar RG, LaRussa P, Galea SA et al. The post marketing safety profile of varicella vaccine. Vaccine 19(7-8), 916–923 (2000).
  • Brisson M, Edmunds WJ, Gay NJ. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. Med. ViroL 70 (Suppl. 1), S31—S37 (2003).
  • Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes zoster: implications for mass vaccination against chickenpox. Vaccine 20(19-20), 2500–2507 (2002).
  • Krause PR, Klinman DM. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children. Nat. Med. 6(4), 451–454 (2000).
  • Zamora I, Simon JM, Da Silva ME, Piqueras Al. Attenuated varicella virus vaccine in children with renal transplants. Pediatr. NephroL 8(2), 190–192 (1994).
  • Ljungman P, Wang FZ, Nilsson C, Solheim V, Linde A. Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study. Support. Care Cancer 11(11), 739–741 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.